Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
171,717,172
-
Total 13F shares
-
85,493,244
-
Share change
-
-2,208,318
-
Total reported value
-
$2,955,555,198
-
Price per share
-
$34.57
-
Number of holders
-
135
-
Value change
-
-$171,240,328
-
Number of buys
-
91
-
Number of sells
-
32
Institutional Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) as of Q1 2021
As of 31 Mar 2021,
Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
85,493,244 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., EcoR1 Capital, LLC, Casdin Capital, LLC, BVF INC/IL, DRIEHAUS CAPITAL MANAGEMENT LLC, Foresite Capital Management IV, LLC, and GILDER GAGNON HOWE & CO LLC.
This page lists
135
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.